Est. 2001·3,000+ placements · six offices · four regions

MitchelLake Intelligence

Oceania

Live market signals and executive-talent analysis across Australia, New Zealand and the Pacific.

AirTrunk · capital raising

Asia funds new growth while the field ships product

Signal tone stays positive — 88% of polar signals point to hiring. product launch leads the wire in 2 of four markets (EMEA, Americas). Asia is the outlier: geographic expansion and capital-raising run 1.5–2.1× their global share there, a fresh capital tilt.

Latest signals — Oceania

ma activity · Oceania

Sigma Healthcare

Sigma Healthcare pursuing $14B acquisition of Boots, facing investor scrutiny and potential shareholder split over bid strategy

International expansion is one of our four key strategic growth pillars. Vikesh Ramsunder

curated · 2026-06-11

leadership change · Oceania

T. Rowe Price

T. Rowe Price promoted Heath Branigan to Head of Intermediary for Australia effective June 1, 2026. Branigan elevated from business development manager role to oversee financial adviser relationships, dealer groups, platforms and strategic partners, reporting to APAC distribution head Elsie Chan.

Many private companies are conducting private fundraising not because they need the capital, but because they require liquidity to retain their talent. Emma Norchet

curated · 2026-06-10

geographic expansion · Oceania

Roland Berger

Roland Berger achieved record €1.01bn revenue in 2025 with Asia growing 19% YoY. Expanded international footprint with new Sydney office and fifth US office in Houston. Also expanded capabilities through acquisitions including battery consulting team and CRO Management entity.

2025 was the most successful year in our firm's history. Our Asia region contributed proportionally more to this growth with +19% year-on-year. This performance is driven by the increasing need for transformation and regionalization of supply chains in Asia, for global as well as Asian multinational companies. Across Asia, addressing regional, as well as export-driven growing demand, requires fast transformation of value chains, from innovation, faster product development cycles to quality and cost improvement in manufacturing. In a turbulent geopolitical context, being the only global strategy consultancy with European roots is a clear competitive advantage for us. Denis Depoux

curated · 2026-06-09

Early stage

≤ series b · ≤ us$30m

US$0.0M

early-stage quantum · trailing 28 days · Oceania

0

qualifying raises

Series B and below, round size ≤ US$30M, verified sources only. The ledger accumulates weekly.

No verified early-stage raises in the current window for Oceania — the freshest venture flow is on the global wire.

Analysis

On the wire — Oceania

Our intelligence attributed 2,135 signals to Oceania in the trailing four weeks. Below is the verified, sourced selection — every entry carries a checked source link and persists as its own page.

David Jones
Nine
Nine Entertainment Co
Elastic
MYOB
Samsara Eco

Last updated

How this connects

Related companies

Recent developments

Related intelligence

Proof — case studies

In their words

Many private companies are conducting private fundraising not because they need the capital, but because they require liquidity to retain their talent.
Emma Norchet, Partner in T. Rowe Price's private opportunities fund investment committee and member of the centralised private equity team for the US equity division, T. Rowe Price Group · context
International expansion is one of our four key strategic growth pillars.
Vikesh Ramsunder, CEO, Sigma Healthcare · context
International growth is one of Sigma's four key strategic growth pillars and the Company remains committed to driving growth in its core offshore markets, while assessing and seeding new markets. This includes the UK where Sigma recently announced a Memorandum of Understanding (MoU) with Greenlight Healthcare. Sigma engaged in the Boots sale process given the potentially unique opportunity it presented to accelerate its UK expansion through the market-leading Boots brand and large footprint. However, following its preliminary review the Company has concluded that such an acquisition would not currently meet its strategic and capital investment objectives.
Sigma Healthcare Ltd, Sigma Healthcare Ltd · context